Organon & Co. Quarterly Liabilities and Equity in USD from Q4 2020 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
Summary
Organon & Co. quarterly Liabilities and Equity history and growth rate from Q4 2020 to Q3 2024.
  • Organon & Co. Liabilities and Equity for the quarter ending September 30, 2024 was $12.8B, a 15.8% increase year-over-year.
Liabilities and Equity, Quarterly (USD)
Liabilities and Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $12.8B +$1.74B +15.8% Sep 30, 2024 10-Q 2024-11-01
Q2 2024 $12.2B +$1.18B +10.7% Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $11.9B +$1.13B +10.5% Mar 31, 2024 10-Q 2024-05-03
Q4 2023 $12.1B +$1.1B +10.1% Dec 31, 2023 10-Q 2024-11-01
Q3 2023 $11B +$575M +5.51% Sep 30, 2023 10-Q 2023-11-03
Q2 2023 $11B +$365M +3.44% Jun 30, 2023 10-Q 2023-08-09
Q1 2023 $10.8B +$166M +1.57% Mar 31, 2023 10-Q 2023-05-05
Q4 2022 $11B +$274M +2.57% Dec 31, 2022 10-K 2024-02-26
Q3 2022 $10.4B -$898M -7.92% Sep 30, 2022 10-Q 2022-11-04
Q2 2022 $10.6B -$294M -2.7% Jun 30, 2022 10-Q 2022-08-05
Q1 2022 $10.6B +$955M +9.91% Mar 31, 2022 10-Q 2022-05-06
Q4 2021 $10.7B +$572M +5.66% Dec 31, 2021 10-K 2023-02-27
Q3 2021 $11.3B Sep 30, 2021 10-Q 2021-11-12
Q2 2021 $10.9B Jun 30, 2021 10-Q 2021-08-16
Q1 2021 $9.64B Mar 31, 2021 10-Q 2021-06-21
Q4 2020 $10.1B Dec 31, 2020 10-K 2022-03-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.